Table 2.
Summary of granted patents on trehalose for dry eye.
| Patent | General Field of Protection 1 | Designated Country |
|---|---|---|
| JP4033510 (B2) | Trehalose for protecting cornea and used as eye drops | JP |
| EP1192947 (B1) | Trehalose in treatment and/or prevention of symptom or sign of Sjögren syndrome | DE FR GB |
| EP1649860 (B1) | Trehalose in treatment of dry eye as a clinical symptom of Sjögren syndrome | DE FR GB |
| US6555526 (B2) | Ophthalmic pharmaceutical composition with trehalose for treatment and/or prevention of symptom and sign in dry eye in Sjögren syndrome | US |
| US7732425 (B2) | Method for treating dry eye (Sjögren syndrome) with trehalose in the form of eyewash solution | US |
| CA2355814 (C) | Ophthalmic pharmaceutical composition with trehalose for treatment and/or prevention of symptom or sign of Sjögren syndrome | CA |
| AU781975 (2001065453) (B2) | Ophthalmic pharmaceutical composition with trehalose for treatment or prevention of symptom or sign of Sjögren syndrome | AU |
| KR100776124 (B1) | Trehalose in treatment and/or prevention of symptom and sign in dry eye in Sjögren syndrome | KR |
| TWI291350 (B) | Trehalose in treatment or prevention of symptom and sign of Sjögren syndrome | TW |
| JP4982643 (B2) | Trehalose in treatment and/or prevention of symptom or sign of Sjögren syndrome | JP |
| EP3110425 (B1) | Trehalose (as a diholoside) with 100–800 kDa HA for treating ophthalmic diseases such as dry eye | Most EPO countries |
1 Descriptive presentation of patent claim(s).